1DAY SOONER ACTION PROJECT INC. for 1DAY SOONER ACTION PROJECT INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN TAYLOR LIVELLI New | — |
Medical/Disease Research/Clinical Labs MED
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN TAYLOR LIVELLI New | — |
Defense DEF
FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN TAYLOR LIVELLI New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.